Login / Signup

Reply to the letter entitled "Suggested treatment of serious complications to Covid-19 vaccination with IdeS, a bacterial antibody-cleaving enzyme".

Yves GruelCaroline VayneJérôme RollinClaire Pouplard
Published in: Journal of thrombosis and haemostasis : JTH (2021)
Keyphrases
  • coronavirus disease
  • sars cov
  • risk factors